PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.76
ESG score 80-90% of INKT's 67.86. Walter Schloss would scrutinize governance quality and regulatory exposure.
59.57
Environmental score 1.1-1.2x INKT's 52.99. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
59.91
Social score below 80% of INKT's 76.49. Jim Chanos would check for potential social license and litigation risks.
59.79
Governance score 80-90% of INKT's 74.09. Walter Schloss would scrutinize management accountability and board independence.